eCommons@AKU
Department of Obstetrics & Gynaecology

Division of Woman and Child Health

October 2013

Wilson’s disease in pregnancy: case series and
review of literature
Ayesha Malik
Aga Khan University

Ali Khawaja
Aga Khan University

Lumaan Sheikh
Aga Khan University, lumaan.sheikh@aku.edu

Follow this and additional works at: http://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_obstet_gynaecol
Part of the Female Urogenital Diseases and Pregnancy Complications Commons, and the
Obstetrics and Gynecology Commons
Recommended Citation
Malik, A., Khawaja, A., Sheikh, L. (2013). Wilson’s disease in pregnancy: case series and review of literature. BMC research notes.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_obstet_gynaecol/72

Malik et al. BMC Research Notes 2013, 6:421
http://www.biomedcentral.com/1756-0500/6/421

CASE REPORT

Open Access

Wilson’s disease in pregnancy: case series and
review of literature
Ayesha Malik1, Ali Khawaja2* and Lumaan Sheikh1

Abstract
Background: Wilson’s disease is a rare, autosomal recessive inherited disorder characterized by impaired liver
metabolism of copper leading to decreased biliary excretion and incorporation of ceruloplasmin levels mainly in
the liver and brain. Untreated Wilson’s disease has been shown to cause subfertility and even in cases where
pregnancy occurs, it often results in spontaneous miscarriage.
Case presentations: We present four cases of successful pregnancy outcomes in three patients diagnosed with
Wilson’s disease along with the literature review. All the patients were managed with zinc sulphate without any
postnatal complications.
Conclusion: Patients with Wilson’s disease receiving regular treatment who remain asymptomatic are usually able
to conceive and achieve successful outcomes. However, these pregnancies should be considered high risk and
merit regular surveillance.
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Background
Wilson’s disease is a rare autosomal recessive disorder with
a prevalence of 1:50,000-1:100,000 live births [1]. Mutation
of ATP 7B on chromosome 13q14 leads to impaired biliary
excretion and ceruloplasmin incorporation causing copper
accumulation mainly in the liver and brain [2]. This accumulation results in liver cirrhosis and nervous system manifestations such as movement disorders and ataxia [3].
Untreated Wilson’s disease usually causes subfertility
and in cases where pregnancy does occur, it often results
in spontaneous miscarriage [4]. However, therapeutic
evolution in the past decades has resulted in multiple
successful pregnancy outcomes in patients with Wilson’s
disease [3-8]. Penicillamine, zinc salts, trientine and
tetrathiomolybdate have been shown to be highly efficacious in treating this disorder [1].
We report four cases of successful pregnancy outcomes
in three women with Wilson’s disease (all treated with zinc)
together with the literature review regarding the impact of
Wilson’s disease on fetomaternal outcomes.
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Case presentations
Case 1

A 30 year old lady presented to our antenatal clinic during the first trimester of her pregnancy. She was diagnosed with Wilson’s disease at the age of twenty two
while being investigated for involuntary generalized
shaking of the body. Her laboratory investigations revealed increased level of copper in the urine and low
serum ceruloplasmin. She was prescribed Zinc Sulphate
50 mg twice daily subsequently. Her brother and a sister
were also diagnosed to have Wilson’s disease. She had
previously conceived on clomiphene after two years of
subfertility but underwent two first trimester miscarriages and a stillbirth at 30 weeks of pregnancy due to
preeclampsia and placental abruption.
During her initial presentation, the patient complained of
headache and tremors for which the neurology team was
consulted. The dose of zinc sulphate was increased to
50 mg thrice a day after which the neurological symptoms
subsided gradually. Ophthalmologic examination revealed
Kayser-Fleischer rings. Serum copper and ceruloplasmin
levels were then obtained which were 76.5 μg/dL (118–
302 μg/dL) and 0.03 g/L (0.25-0.63 g/L), respectively.
Maternal echocardiogram was performed which was within
normal limits while ultrasound of the upper abdomen
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revealed inflammatory changes in the liver with
echogenicity of the parenchyma. An anomaly scan was
performed at 20 weeks of gestation which did not reveal
any congenital anomaly while a growth scan performed at
35 weeks of gestation showed a live fetus weighing 2.5 kg
and having adequate amniotic fluid index. Renal and liver
function tests remained within normal limits throughout
the pregnancy. Serum copper level was again obtained at
30 weeks of gestation which was 30.72 μg/dL.
The patient underwent spontaneous labour at 37 weeks
of gestation. Intra-partum course of events was unremarkable and a healthy baby boy weighing 3 kg with a
good Apgar score was delivered vaginally.
Case 2

A 33 year old lady with a prior history of a missed miscarriage, presented to our antenatal clinic at six weeks of
gestation. She was diagnosed to have Wilson’s disease
four years ago while undergoing evaluation for muscle
weakness. The urinary copper level was high while
serum copper and cerulopasmin levels were found to be
below normal limits and she was started on zinc
sulphate three times a day.
The patient had conceived spontaneously and was
asymptomatic at the time of presentation. Zinc sulphate
was continued at 30 mg thrice a day throughout her pregnancy. As a part of her baseline workup, an ultrasound
upper abdomen was performed which showed portal
hypertension. Serum copper level was 33 μg/dL while
serum ceruloplasmin was 0.05 g/L. The blood pressure during her first antenatal visit was within normal limits. However, it was found to be raised (150/100 mmHg) at
18 weeks of gestation due to which methyldopa 500 mg
three times a day was started subsequently. Blood pressure
on her following visits remained between 130/80 mmHg
and 140/90 mmHg. Anomaly scan performed at 22 weeks
of gestation did not reveal any congenital anomaly. At
24 weeks of gestation, 50 grams glucose challenge test was
performed for screening of gestational diabetes mellitus
which was found to be deranged; one hour value of
177 mg/dl (normal value = 140 mg/dl). Oral glucose tolerance test was therefore performed which also revealed
raised blood glucose levels confirming the diagnosis of gestational diabetes mellitus. Her sugars, however, remained
well controlled through dietary measures throughout the
antenatal period. A growth scan was performed at 34 weeks
of gestation which showed a live fetus with an estimated
fetal weight of 2.1 kg with normal amniotic fluid index.
Serum copper and ceruloplasmin levels performed during
this time period were 70.86 μg/dL and 0.07 g/L, respectively. During her 38th week of pregnancy, she developed
preeclampsia with a blood pressure of 140/95 mmHg and
proteinuria of 0.3 mg/dl. Therefore, induction of labour
was offered. The bishop score prior to the induction was
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four and cervical ripening was performed through an intracervical foley’s catheter followed by an intra-vaginal prostaglandin E2. Syntocinon was later started at a cervical dilatation of 3 cm. However, an emergency caesarean section had
to be performed due to non-progress of labour. An alive
baby boy weighing 3.3 kg with a good Apgar score was delivered successfully. Her blood pressure normalized during
the postpartum period. One year later, the patient had another spontaneous pregnancy which terminated in a missed
miscarriage at 7 weeks of gestation.
Case 3

A 21 year old primigravida, presented to our antenatal
clinic for her booking appointment. She was diagnosed
to have Wilson’s disease at the age of eighteen years
when she started having symptoms of depression. The
laboratory workup revealed an elevated level of copper
in the urine (250 μg/day; normal value <60 μg/day) and
low serum ceruloplasmin level (0.1 g/l; normal range
0.25-0.63 g/l). Her father was also diagnosed to have
Wilson’s disease. She had been using zinc sulphate
60 mg three times a day and relaxipam 2 mg daily since
the time of diagnosis and continued it throughout her
pregnancy.
The patient did not have any symptoms of Wilson’s
disease at the time of presentation. All the antenatal laboratory tests were within normal limits. Urinary copper
level was obtained at the tenth week of gestation which
was 2.88 μg/day. Anomaly scan performed at 20 weeks
revealed no gross congenital anomalies while the growth
scan done at the 30th week of gestation showed satisfactory growth of the fetus. Maternal echocardiography
performed at 24 weeks did not reveal any abnormality
with an ejection fraction of 60%. Oral glucose tolerance
test was obtained at the 24th week of gestation which
ruled out gestational diabetes.
Antenatal course was uneventful except for the two
episodes of gastroenteritis at the 23rd and 36th week of
gestation for which she was admitted and managed
conservatively.
At 40 weeks of gestation, she was admitted electively
for the induction of labor. Bishop score at the time of
admission was six. The induction of labour was initiated
with an intracervical foley’s catheter followed by an
intravaginal prostaglandin E2. Amniotomy was subsequently performed followed by intravenous oxytocin
once the contractions started. During her intrapartum
monitoring, blood pressure was found to be escalating
and due to a persistently raised diastolic pressure of
100 mmHg, an intravenous hydralazine was administered. Spot protein/creatinine ratio obtained during this
time period was 0.33 mg/dl which was suggestive of preeclampsia. However, labour progressed satisfactorily and
the patient delivered an alive baby boy weighing 3.4 kg
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with a good Apgar score via spontaneous vaginal delivery. In the post partum period, blood pressure remained
within normal limits on 5 mg of amlodipine.
Case 4

The same patient conceived spontaneously one year later.
Her antenatal visits were regular and unremarkable. She
was asymptomatic for Wilson’s disease throughout the
pregnancy. Serum ceruloplasmin levels were checked at 24
and 36 weeks of gestation which were 0.73 and 0.75 g/L, respectively. Anomaly and Growth scans were unremarkable.
At 38 weeks of gestation, she presented with complains of abdominal heaviness, stiffness, vomiting and
raised blood pressure of 140/100 mmHg. Urinalysis was
negative for proteinuria while full blood count, liver
function tests and uric acid were within normal limits.
She was admitted and planned for induction of labor.
Intrapartum period remained uneventful culminating
in a spontaneous vaginal delivery of a healthy baby boy
weighing 3.5 kg. Patient remained normotensive in the
postpartum period and was discharged on the second
postnatal day.
In all our patients, serum ceruloplasmin level was
ascertained by nephlometric method while urinary and
serum copper levels were determined by FASS (flame
atomic absorption spectrometry) methodology.

Discussion
Although there are a few case reports pertaining to successful pregnancy outcomes in women with Wilson’s
disease [3-8], the present case series enforces the effectiveness of zinc sulphate in managing pregnancies in patients diagnosed with Wilson’s disease.
Liver is the primary storage organ for copper after
which it can be distributed in circulation to other tissues
such as nervous system, eyes and kidneys. Accumulation
of excessive copper due to decreased excretion can adversely affect these tissues leading to hepatic injury and
cirrhosis, neurological symptoms such as dyskinesias
and tremors, kayser-fleishcer ring around limbus and
renal tubular damage [9]. Moreover, it can lead to menstrual irregularities due to hepatotoxicity and recurrent
miscarriages due to copper deposition in the uterus in
women in reproductive age group [1,4]. Women with
Wilson’s disease may require infertility treatment but
many patients conceive spontaneously. In our case
series, one patient received clomephine citrate. However,
women with severe liver disease leading to bleeding episodes from eosophageal varices or hepatic insufficiency
are usually discouraged from getting pregnant [8].
The serum copper and ceruloplasmin levels have been
observed to change as the pregnancy progresses. The
levels may increase till 24 weeks followed by a modest
decline probably due to fetal intake of copper [7]. There
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is approximately 12 mg of copper in a neonate and the
fetus is thought to remove an average of 0.044 mg of
copper per day from the maternal serum, due to which
improvement in symptoms of Wilson’s disease have also
been reported [7,10].
Untreated, Wilson’s disease may lead to early pregnancy
complications [4]. Two out of three of our patients had at
least one miscarriage. The mechanism has been postulated
to be similar to that of copper containing contraceptive devices which exert their contraceptive effect by causing deposition of copper in the endometrium giving rise to an
excess of copper ions [11]. Such high concentrations of
intrauterine copper may lead to miscarriages as seen in patients with Wilson’s disease.
Wilson’s disease, if not treated promptly, can lead to
significant morbidity and can be potentially fatal. It is
hence imperative that it is identified early and treated effectively. Safety of Pencillamine in managing Wilson’s
disease during pregnancy has been reported by multiple
studies [4-6,8]. Only one case report states an infant developing connective tissue disorder in a mother with a
daily intake of 2 grams of pencillamine which is approximately twice the dose used for Wilson’s disease in pregnancy [12]. It has also been suggested to reduce the dose
of pencillamine to 0.25 grams per day, one to six weeks
prior to a caesarean section in order to prevent delayed
wound healing [13-15]. Trientine is an oral chelating
drug used as an alternate when patients develop a reaction to pencillamine. Its effectiveness has been proven
and case reports regarding its use in pregnancy do not
show any adverse fetomaternal outcomes [16,17].
More recently, zinc is increasingly being used as a
therapeutic option in managing Wilson’s disease. Zinc
interferes with the absorption of copper from the gastrointestinal tract; however, its long-term side-effects are
still not well studied. Zinc performs its function by induction of intestinal cells metallothionein which has a
high affinity for copper and prevents serosal transfer of
copper into blood [18]. Brewer et al. reports use of Zinc
Sulphate in 26 pregnancies out of which 24 had a normal infant, one infant had a congenital heart defect and
one had microcephaly [10]. In our case series, all the patients were treated with zinc sulphate without occurrence of any congenital anomaly in the neonates.
In our case series, three out of four pregnancies were
complicated with pregnancy induced hypertension/preeclampsia. This complication has been reported previously
in patients with Wilson’s disease [1,19]. It may be hypothesized that these patients are at risk of developing pregnancy
induced hypertension or preeclampsia. However, it is still
unknown if this finding is related to the presence of the
underlying disease or is related to the anti-copper therapy
used during pregnancy. These patients might be at risk for
other complications including placental abruption and
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thrombocytopenia and deranged coagulation [3,19,20].
However, such complications were not encountered in our
patients.

Conclusions
Patients with Wilson’s disease receiving regular treatment
who remain asymptomatic are usually able to conceive with
successful outcomes. Zinc Sulphate is an effective therapeutic option and can be safely used in managing patients
with Wilson’s disease throughout the pregnancy. However,
since there seems to be an association of Wilson’s disease
with miscarriages and pregnancy induced hypertension/
preeclampsia, these pregnancies should be considered high
risk and merit regular surveillance.
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